Kazokaitė J , Aspatwar A , Parkkila S , Matulis D .

Figure 1. Methods which might be applied for developing CA IX-targeting compounds before pre-clinical characterization in tumor cells and mice.

Aggarwal, Structural annotation of human carbonic anhydrases. 2013, Pubmed

Aggarwal, Structural annotation of human carbonic anhydrases. 2013, Pubmed
Ahlskog, In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives. 2009, Pubmed
Ahlskog, Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours. 2009, Pubmed
Akocak, PEGylated Bis-Sulfonamide Carbonic Anhydrase Inhibitors Can Efficiently Control the Growth of Several Carbonic Anhydrase IX-Expressing Carcinomas. 2016, Pubmed
Akıncıoğlu, Novel sulfamides as potential carbonic anhydrase isoenzymes inhibitors. 2013, Pubmed
Alterio, Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX. 2009, Pubmed
Alterio, Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? 2012, Pubmed
Ameis, Carbonic anhydrase IX correlates with survival and is a potential therapeutic target for neuroblastoma. 2016, Pubmed
Baranauskienė, Intrinsic thermodynamics of ethoxzolamide inhibitor binding to human carbonic anhydrase XIII. 2012, Pubmed
Beck, Strategies and challenges for the next generation of antibody-drug conjugates. 2017, Pubmed
Bertout, The impact of O2 availability on human cancer. 2008, Pubmed
Betof, Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification. 2012, Pubmed
Bozdag, Coumarins and other fused bicyclic heterocycles with selective tumor-associated carbonic anhydrase isoforms inhibitory activity. 2017, Pubmed
Buller, Selection of Carbonic Anhydrase IX Inhibitors from One Million DNA-Encoded Compounds. 2011, Pubmed
Capasso, An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria? 2015, Pubmed
Cardone, The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. 2005, Pubmed
Carta, Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo. 2012, Pubmed
Carta, Xanthates and trithiocarbonates strongly inhibit carbonic anhydrases and show antiglaucoma effects in vivo. 2013, Pubmed
Carta, Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. 2010, Pubmed
Cazzamalli, Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma. 2017, Pubmed
Cecchi, Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors. 2005, Pubmed
Cheng, Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. 1973, Pubmed
Choschzick, Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer. 2011, Pubmed
Chrastina, Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody. 2003, Pubmed
Chrastina, Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma. 2003, Pubmed
Cimmperman, A quantitative model of thermal stabilization and destabilization of proteins by ligands. 2008, Pubmed
Couvelard, Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. 2005, Pubmed
Cummings, Universal screening methods and applications of ThermoFluor. 2006, Pubmed
D'Ambrosio, Out of the active site binding pocket for carbonic anhydrase inhibitors. 2015, Pubmed
Davis, A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma. 2007, Pubmed
Davis, Natural product polyamines that inhibit human carbonic anhydrases. 2014, Pubmed
Dekaminaviciute, Monoclonal antibodies raised against 167-180 aa sequence of human carbonic anhydrase XII inhibit its enzymatic activity. 2014, Pubmed
Del Prete, Biochemical characterization of the δ-carbonic anhydrase from the marine diatom Thalassiosira weissflogii, TweCA. 2014, Pubmed
Denko, Hypoxia, HIF1 and glucose metabolism in the solid tumour. 2008, Pubmed
DiTusa, Thermodynamics of metal ion binding. 1. Metal ion binding by wild-type carbonic anhydrase. 2001, Pubmed
Dittrich, A phase I and pharmacokinetic study of indisulam in combination with carboplatin. 2007, Pubmed
Divgi, Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial. 2007, Pubmed
Dubois, Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs. 2013, Pubmed
Dudutienė, Discovery and characterization of novel selective inhibitors of carbonic anhydrase IX. 2014, Pubmed
Dudutienė, 4-Substituted-2,3,5,6-tetrafluorobenzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII. 2013, Pubmed
Dudutienė, Functionalization of fluorinated benzenesulfonamides and their inhibitory properties toward carbonic anhydrases. 2015, Pubmed
Eriksson, Refined structure of human carbonic anhydrase II at 2.0 A resolution. 1988, Pubmed
Falconer, Applications of isothermal titration calorimetry - the research and technical developments from 2011 to 2015. 2016, Pubmed
Fisher, Atomic crystal and molecular dynamics simulation structures of human carbonic anhydrase II: insights into the proton transfer mechanism. 2007, Pubmed
Fox, Interactions between Hofmeister anions and the binding pocket of a protein. 2015, Pubmed
Frost, Physiological functions of the alpha class of carbonic anhydrases. 2014, Pubmed
GIBBONS, RATE OF HYDRATION OF CARBON DIOXIDE AND DEHYDRATION OF CARBONIC ACID AT 25 DEGREES. 1963, Pubmed
GIBBONS, KINETIC STUDIES OF HUMAN CARBONIC ANHYDRASES B AND C. 1964, Pubmed
Garousi, Comparative Evaluation of Affibody Molecules for Radionuclide Imaging of in Vivo Expression of Carbonic Anhydrase IX. 2016, Pubmed
Geschwindner, Ligand Binding Thermodynamics in Drug Discovery: Still a Hot Tip? 2015, Pubmed
Good, The hallmarks of cancer and the radiation oncologist: updating the 5Rs of radiobiology. 2013, Pubmed
Groves, Synthesis and evaluation of near-infrared fluorescent sulfonamide derivatives for imaging of hypoxia-induced carbonic anhydrase IX expression in tumors. 2012, Pubmed
Hanahan, Hallmarks of cancer: the next generation. 2011, Pubmed
Hashim, Imaging pH and metastasis. 2011, Pubmed
Huang, Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma. 2015, Pubmed
Höckel, Hypoxia and Radiation Response in Human Tumors. 1996, Pubmed
Innocenti, Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV). 2008, Pubmed
Innocenti, Carbonic anhydrase inhibitors. Inhibition of transmembrane isoforms IX, XII, and XIV with less investigated anions including trithiocarbonate and dithiocarbamate. 2010, Pubmed
Izatt, Thermodynamics of proton dissociation in dilute aqueous solution. V. An entropy titration study of adenosine, pentoses, hexoses, and related compounds. 1966, Pubmed
Jecklin, Label-free determination of protein-ligand binding constants using mass spectrometry and validation using surface plasmon resonance and isothermal titration calorimetry. 2009, Pubmed
Jogaitė, Characterization of human carbonic anhydrase XII stability and inhibitor binding. 2013, Pubmed
Jönsson, Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. 1991, Pubmed
Kanfar, Effective Access to Multivalent Inhibitors of Carbonic Anhydrases Promoted by Peptide Bioconjugation. 2017, Pubmed
Kanfar, Emerging trends in enzyme inhibition by multivalent nanoconstructs. 2015, Pubmed
Kazokaitė, Selective inhibition of human carbonic anhydrase IX in Xenopus oocytes and MDA-MB-231 breast cancer cells. 2016, Pubmed , Xenbase
Kazokaitė, Intrinsic binding of 4-substituted-2,3,5,6-tetrafluorobenezenesulfonamides to native and recombinant human carbonic anhydrase VI. 2015, Pubmed
Kazokaitė, Fluorinated benzenesulfonamide anticancer inhibitors of carbonic anhydrase IX exhibit lower toxic effects on zebrafish embryonic development than ethoxzolamide. 2017, Pubmed
Khalifah, Thermodynamics of binding of the CO2-competitive inhibitor imidazole and related compounds to human carbonic anhydrase I: an isothermal titration calorimetry approach to studying weak binding by displacement with strong inhibitors. 1993, Pubmed
Khalifah, The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. 1971, Pubmed
Kikutani, Thylakoid luminal θ-carbonic anhydrase critical for growth and photosynthesis in the marine diatom Phaeodactylum tricornutum. 2016, Pubmed
Klebe, Applying thermodynamic profiling in lead finding and optimization. 2015, Pubmed
Klier, Catalytic activity of human carbonic anhydrase isoform IX is displayed both extra- and intracellularly. 2016, Pubmed , Xenbase
Klinger, Inhibition of carbonic anhydrase-II by sulfamate and sulfamide groups: an investigation involving direct thermodynamic binding measurements. 2006, Pubmed
Kotch, Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. 1999, Pubmed
Krall, A small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors. 2014, Pubmed
Kranz, Protein thermal shifts to identify low molecular weight fragments. 2011, Pubmed
Krimmer, Thermodynamics of protein-ligand interactions as a reference for computational analysis: how to assess accuracy, reliability and relevance of experimental data. 2015, Pubmed
Krishnamurthy, Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding. 2008, Pubmed
Li, Antibody-specific detection of CAIX in breast and prostate cancers. 2009, Pubmed
Li, Hypoxia induced CCR7 expression via HIF-1alpha and HIF-2alpha correlates with migration and invasion in lung cancer cells. 2009, Pubmed
Lin, Zebrafish and Medaka: new model organisms for modern biomedical research. 2016, Pubmed
Linkuvienė, Intrinsic thermodynamics of inhibitor binding to human carbonic anhydrase IX. 2016, Pubmed
Lo, Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. 2004, Pubmed
Lock, Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche. 2013, Pubmed
Logsdon, Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models. 2016, Pubmed
Lomelino, Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011-2016). 2016, Pubmed
Lou, Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. 2011, Pubmed
Lv, Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers. 2016, Pubmed
MacRae, Zebrafish as tools for drug discovery. 2015, Pubmed
Mazzio, Evaluation of endogenous acidic metabolic products associated with carbohydrate metabolism in tumor cells. 2010, Pubmed
McDonald, Recent developments in targeting carbonic anhydrase IX for cancer therapeutics. 2012, Pubmed
Mezzasalma, Enhancing recombinant protein quality and yield by protein stability profiling. 2007, Pubmed
Monti, Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013). 2013, Pubmed
Morkūnaitė, Saccharin sulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII. 2014, Pubmed
Morkūnaitė, Intrinsic thermodynamics of sulfonamide inhibitor binding to human carbonic anhydrases I and II. 2015, Pubmed
Morrison, Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors. 1969, Pubmed
Myszka, Analysis of small-molecule interactions using Biacore S51 technology. 2004, Pubmed
Métayer, Superacid synthesized tertiary benzenesulfonamides and benzofuzed sultams act as selective hCA IX inhibitors: toward understanding a new mode of inhibition by tertiary sulfonamides. 2013, Pubmed
Navratilova, Fragment screening by surface plasmon resonance. 2010, Pubmed
Niesen, The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. 2007, Pubmed
Nocentini, 7-Aryl-triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrase IX and XII. 2016, Pubmed
Nocentini, Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII. 2015, Pubmed
O'Toole, Hypoxia induces epidermal keratinocyte matrix metalloproteinase-9 secretion via the protein kinase C pathway. 2008, Pubmed
Obach, 6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia. 2004, Pubmed
Oosterwijk, Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. 1986, Pubmed
Pacchiano, Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. 2011, Pubmed
Pal, Kidney cancer: Finding a niche for girentuximab in metastatic renal cell carcinoma. 2016, Pubmed
Pantoliano, High-density miniaturized thermal shift assays as a general strategy for drug discovery. 2001, Pubmed
Papalia, Comparative analysis of 10 small molecules binding to carbonic anhydrase II by different investigators using Biacore technology. 2006, Pubmed
Parkkila, The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian alpha-carbonic anhydrase isoforms. 2009, Pubmed
Parks, Disrupting proton dynamics and energy metabolism for cancer therapy. 2013, Pubmed
Pastorek, Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use. 2015, Pubmed
Pastorekova, Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxia. 2008, Pubmed
Pastoreková, Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. 1997, Pubmed
Pilipuitytė, Intrinsic thermodynamics of trifluoromethanesulfonamide and ethoxzolamide binding to human carbonic anhydrase VII. 2015, Pubmed
Pinard, Probing the surface of human carbonic anhydrase for clues towards the design of isoform specific inhibitors. 2015, Pubmed
Pocker, Carbonic anhydrase: structure catalytic versatility, and inhibition. 1978, Pubmed
Ramchandani, Activation of carbonic anhydrase IX by alternatively spliced tissue factor under late-stage tumor conditions. 2016, Pubmed
Ramsay, Direct measurement of the energetics of association between myelin basic protein and phosphatidylserine vesicles. 1986, Pubmed
Rennekamp, 15 years of zebrafish chemical screening. 2015, Pubmed
Rutkauskas, 4-amino-substituted benzenesulfonamides as inhibitors of human carbonic anhydrases. 2014, Pubmed
Ryu, Hypoxia-inducible factor-1alpha mediates oral squamous cell carcinoma invasion via upregulation of alpha5 integrin and fibronectin. 2010, Pubmed
Santos, Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties. 2007, Pubmed
Schneider, GPI-anchored carbonic anhydrase IV displays both intra- and extracellular activity in cRNA-injected oocytes and in mouse neurons. 2013, Pubmed , Xenbase
Schön, Thermodynamics of intersubunit interactions in cholera toxin upon binding to the oligosaccharide portion of its cell surface receptor, ganglioside GM1. 1989, Pubmed
Sedlakova, Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors. 2014, Pubmed
Semenza, Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. 2014, Pubmed
Siebels, A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients. 2011, Pubmed
Smirnovienė, Picomolar inhibitors of carbonic anhydrase: Importance of inhibition and binding assays. 2017, Pubmed
Stillebroer, Radiolabeled antibodies in renal cell carcinoma. 2007, Pubmed
Stiti, Carbonic anhydrase inhibitor coated gold nanoparticles selectively inhibit the tumor-associated isoform IX over the cytosolic isozymes I and II. 2008, Pubmed
Supuran, Carbonic anhydrase inhibitors: an editorial. 2013, Pubmed
Supuran, How many carbonic anhydrase inhibition mechanisms exist? 2016, Pubmed
Supuran, The η-class carbonic anhydrases as drug targets for antimalarial agents. 2015, Pubmed
Supuran, Structure-based drug discovery of carbonic anhydrase inhibitors. 2012, Pubmed
Supuran, Carbonic anhydrase IX inhibitors in cancer therapy: an update. 2015, Pubmed
Supuran, Advances in structure-based drug discovery of carbonic anhydrase inhibitors. 2017, Pubmed
Surfus, Anti-renal-cell carcinoma chimeric antibody G250 facilitates antibody-dependent cellular cytotoxicity with in vitro and in vivo interleukin-2-activated effectors. 1996, Pubmed
Svastova, Carbonic anhydrase IX interacts with bicarbonate transporters in lamellipodia and increases cell migration via its catalytic domain. 2012, Pubmed
Svastová, Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. 2004, Pubmed
Swietach, New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation. 2010, Pubmed
Tafreshi, Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes. 2012, Pubmed
Takubo, Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. 2010, Pubmed
Talibov, Kinetically Selective Inhibitors of Human Carbonic Anhydrase Isozymes I, II, VII, IX, XII, and XIII. 2016, Pubmed
Tars, Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases. 2013, Pubmed
Tashian, Esterase and hydrase activity of carbonic anhydrase. I. From primate erythrocytes. 1964, Pubmed
Touisni, Fluorescent Silica Nanoparticles with Multivalent Inhibitory Effects towards Carbonic Anhydrases. 2015, Pubmed
Uda, Esterase activity of carbonic anhydrases serves as surrogate for selecting antibodies blocking hydratase activity. 2015, Pubmed
Ullah, The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. 2006, Pubmed
Vander Heiden, Understanding the Warburg effect: the metabolic requirements of cell proliferation. 2009, Pubmed
WARBURG, On respiratory impairment in cancer cells. 1956, Pubmed
Welti, Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. 2013, Pubmed
Wilson, Targeting hypoxia in cancer therapy. 2011, Pubmed
Wojtkowiak, Drug resistance and cellular adaptation to tumor acidic pH microenvironment. 2011, Pubmed
Xu, Internalization, Trafficking, Intracellular Processing and Actions of Antibody-Drug Conjugates. 2015, Pubmed
Yang, Increased expression of carbonic anhydrase IX in oral submucous fibrosis and oral squamous cell carcinoma. 2014, Pubmed
Zat'ovicová, Monoclonal antibodies generated in carbonic anhydrase IX-deficient mice recognize different domains of tumour-associated hypoxia-induced carbonic anhydrase IX. 2003, Pubmed
Zatovicova, Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain. 2010, Pubmed
Zubrienė, Intrinsic thermodynamics of 4-substituted-2,3,5,6-tetrafluorobenzenesulfonamide binding to carbonic anhydrases by isothermal titration calorimetry. 2015, Pubmed
Zubrienė, Benzenesulfonamides with benzimidazole moieties as inhibitors of carbonic anhydrases I, II, VII, XII and XIII. 2014, Pubmed
Závada, Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. 1993, Pubmed
van Kuijk, Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis. 2016, Pubmed
Čapkauskaitė, Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII. 2013, Pubmed